The Press Office provides journalists with information on the diverse range of subjects that are relevant to the pharmaceutical industry. Our role is to ensure that any type of media is able to have access to the industry perspective and opinion.
- ABPI responds to news of generic price hikes, repeating that it does not "in any way support or condone it"Read more
Enhancing the reputation of the pharmaceutical industry, improving access to innovative medicines for NHS patients and ensuring a UK environment that enables the Life Sciences industry to thrive are the three key priorities for Lisa Anson as she begins her two-year Presidency of the Association of the British Pharmaceutical Industry. Read more
The new Government must be more ambitious in securing a world-class NHS for patients and improve access to medicines in line with other developed nations.Read more
GENEVA: On the occasion of the 5th anniversary of the World Health Organization’s roadmap on NTDs and the London Declaration, IFPMA released today its latest report “Doing our part – Innovating to fight Neglected Tropical Diseases” that provides the most up-to-date record of active research and development (R&D) projects for the next generation of medicines and vaccines for NTDs[i].Read more
The Association of the British Pharmaceutical Industry (ABPI) have issued the following statement on the calling of a snap General Election.Read more
The Association of the British Pharmaceutical Industry (ABPI) has responded to today’s House of Lords Long-Term Sustainability of the NHS Committee report.Read more
In a new snapshot survey of leading pharmaceutical businesses in the UK, companies have said that changes to the way the National Institute for Health & Care Excellence (NICE) and NHS England (NHSE) assess new medicines, coming in to effect today (1 April 2017), will decrease access to the latest treatments, with new medicines for cancer set to be impacted the most.Read more
The NHS has today (31 March) published its 'Next Steps On The NHS Five Year Forward View'. Read more
The Association of the British Pharmaceutical Industry (ABPI) has responded to today’s triggering of Article 50 of the Lisbon Treaty by Prime Minister Theresa May, officially starting the process of the United Kingdom (UK) negotiating its departure from the European Union (EU).Read more
New data shows research and development spend up to £254 million and a revised consent to disclose figure of 55%.